FIELD: medicine.
SUBSTANCE: invention relates to novel pharmaceutical composition in form of lyophilizate. Lyophilizate is obtained by lyophilic drying of emulsion of "oil in water" type based of lecithin. Emulsion contains badly soluble in water or in oil active substance, effective quantity of antioxidant, emulsion stabiliser, dimethylsulphoxide, copolymer of lactide and glycolide and additive, which prevents enlargement of emulsion particles during freezing. Lyophilizate is characterised by high stability when dissolved by infusion liquids.
EFFECT: reconstructing of emulsion is realised during not more than 15 minutes and without application of additional equipment, restored emulsion containing not less than 80% of particles with size less than 200 nm.
19 cl, 3 dwg, 3 tbl, 8 ex
| Title | Year | Author | Number |
|---|---|---|---|
| STABLE EMULSION FOR PARENTERAL INTRODUCTION OF BADLY SOLUBLE IN WATER COMPOUNDS, WHICH HAVE ANTI-TUMOR ACTIVITY, AND METHOD OF ITS OBTAINING | 2007 |
|
RU2370261C2 |
| METHOD FOR OBTAINING POLYMERIC ANTI-TUMOR PARTICLES IN FLOW MICROREACTOR AND LYOPHILISATE BASED ON THEM | 2018 |
|
RU2681933C1 |
| PHARMACEUTICAL COMPOSITION FOR CHEMOTHERAPY OF ONCOLOGICAL DISEASES AND METHOD OF ITS PREPARATION | 2016 |
|
RU2617511C1 |
| PHARMACEUTICAL COMPOSITION OF TAXAN, SOLID COMPOSITION OF TAXAN, METHOD OF PRODUCING SOLID COMPOSITION OF TAXAN, COMPOSITION FOR SOLUBILISATION OF SAID SOLID COMPOSITION OF TAXAN AND SET OF ELEMENTS (KIT) FOR COMPOSITION OF TAXAN FOR INJECTIONS | 2007 |
|
RU2429837C2 |
| PROLONGED RELEASE FORMULATION CONTAINING OCTREOTIDE AND THREE LINEAR POLYMERS OF POLY(LACTIDE-CO-GLYCOLIC ACID) | 2009 |
|
RU2541104C2 |
| METHOD FOR PREPARING A PHARMACEUTICAL COMPOSITION CONTAINING CINNARIZINE | 2019 |
|
RU2727964C1 |
| OCTREOTIDE-CONTAINING COMPOSITION WITH DELAYED RELEASE WITH STABLY HIGH LEVEL OF IMPACT | 2009 |
|
RU2526822C2 |
| COMPOSITIONS AND WAYS OF PHARMACOLOGICAL AGENTS DELIVERY | 2003 |
|
RU2361615C2 |
| COMPOSITIONS AND METHODS OF DELIVERY OF PHARMACOLOGICAL AGENTS | 2009 |
|
RU2522977C2 |
| COMPOSITION FOR ORAL DELIVERY OF BIOACTIVE AGENTS | 2014 |
|
RU2688136C1 |
